FilingSEC EDGAR424B5
Fate Therapeutics Establishes $100 Million ATM Offering Program
· SEC accepted
StageOngoing
Filing content
The company entered into a sales agreement with Leerink Partners to offer and sell up to $100 million of common stock from time to time, terminating its prior agreement with Jefferies.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…